# ASP8825 - Study in Patients With Restless Legs Syndrome

> **NCT00530530** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 474 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** ASP8825
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00530530
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530530, "ASP8825 - Study in Patients With Restless Legs Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00530530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*